252 related articles for article (PubMed ID: 34272689)
1. Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics.
Seibert E; Tracy TS
Methods Mol Biol; 2021; 2342():3-27. PubMed ID: 34272689
[TBL] [Abstract][Full Text] [Related]
2. Different enzyme kinetic models.
Seibert E; Tracy TS
Methods Mol Biol; 2014; 1113():23-35. PubMed ID: 24523107
[TBL] [Abstract][Full Text] [Related]
3. Atypical cytochrome p450 kinetics: implications for drug discovery.
Tracy TS
Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
[TBL] [Abstract][Full Text] [Related]
4. Atypical Michaelis-Menten kinetics in cytochrome P450 enzymes: A focus on substrate inhibition.
Leow JWH; Chan ECY
Biochem Pharmacol; 2019 Nov; 169():113615. PubMed ID: 31445022
[TBL] [Abstract][Full Text] [Related]
5. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.
Atkins WM
Annu Rev Pharmacol Toxicol; 2005; 45():291-310. PubMed ID: 15832445
[TBL] [Abstract][Full Text] [Related]
6. The prothrombinase reaction: "mechanism switching" between Michaelis-Menten and non-Michaelis-Menten behaviors.
Lu Y; Nelsestuen GL
Biochemistry; 1996 Jun; 35(25):8201-9. PubMed ID: 8679574
[TBL] [Abstract][Full Text] [Related]
7. Enzyme Kinetics of Oxidative Metabolism-Cytochromes P450.
Korzekwa K
Methods Mol Biol; 2021; 2342():237-256. PubMed ID: 34272697
[TBL] [Abstract][Full Text] [Related]
8. Enzyme kinetics of cytochrome P450-mediated reactions.
Shou M; Lin Y; Lu P; Tang C; Mei Q; Cui D; Tang W; Ngui JS; Lin CC; Singh R; Wong BK; Yergey JA; Lin JH; Pearson PG; Baillie TA; Rodrigues AD; Rushmore TH
Curr Drug Metab; 2001 Mar; 2(1):17-36. PubMed ID: 11465149
[TBL] [Abstract][Full Text] [Related]
9. Exact and approximate solutions for the decades-old Michaelis-Menten equation: Progress-curve analysis through integrated rate equations.
Goličnik M
Biochem Mol Biol Educ; 2011; 39(2):117-25. PubMed ID: 21445903
[TBL] [Abstract][Full Text] [Related]
10. A guide to the Michaelis-Menten equation: steady state and beyond.
Srinivasan B
FEBS J; 2022 Oct; 289(20):6086-6098. PubMed ID: 34270860
[TBL] [Abstract][Full Text] [Related]
11. A new multi-wavelength model-based method for determination of enzyme kinetic parameters.
Sorouraddin MH; Amini K; Naseri A; Vallipour J; Hanaee J; Rashidi MR
J Biosci; 2010 Sep; 35(3):395-403. PubMed ID: 20826949
[TBL] [Abstract][Full Text] [Related]
12. Modeling kinetic data from in vitro drug metabolism enzyme experiments.
Tracy TS; Hummel MA
Drug Metab Rev; 2004 May; 36(2):231-42. PubMed ID: 15237853
[TBL] [Abstract][Full Text] [Related]
13. Final phase of enzyme reactions following a Michaelis-Menten mechanisms in which the free enzyme and/or the enzyme-substrate complex are unstable.
Varón R; Garrido del Solo C; García-Moreno M; Sánchez-Gracia A; García-Cánovas F
Biol Chem Hoppe Seyler; 1994 Jan; 375(1):35-42. PubMed ID: 8003255
[TBL] [Abstract][Full Text] [Related]
14. Enzyme kinetics of oxidative metabolism: cytochromes P450.
Korzekwa K
Methods Mol Biol; 2014; 1113():149-66. PubMed ID: 24523112
[TBL] [Abstract][Full Text] [Related]
15. Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from "distributive catalysis".
Atkins WM; Lu WD; Cook DL
J Biol Chem; 2002 Sep; 277(36):33258-66. PubMed ID: 12082118
[TBL] [Abstract][Full Text] [Related]
16. Conformational Nonequilibrium Enzyme Kinetics: Generalized Michaelis-Menten Equation.
Piephoff DE; Wu J; Cao J
J Phys Chem Lett; 2017 Aug; 8(15):3619-3623. PubMed ID: 28737397
[TBL] [Abstract][Full Text] [Related]
17. Enzyme inhibition studies by integrated Michaelis-Menten equation considering simultaneous presence of two inhibitors when one of them is a reaction product.
Bezerra RM; Pinto PA; Fraga I; Dias AA
Comput Methods Programs Biomed; 2016 Mar; 125():2-7. PubMed ID: 26777432
[TBL] [Abstract][Full Text] [Related]
18. A test for measuring the effects of enzyme inactivation.
Schnell S; Hanson SM
Biophys Chem; 2007 Feb; 125(2-3):269-74. PubMed ID: 17011111
[TBL] [Abstract][Full Text] [Related]
19. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
[TBL] [Abstract][Full Text] [Related]
20. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.
Houston JB; Kenworthy KE
Drug Metab Dispos; 2000 Mar; 28(3):246-54. PubMed ID: 10681367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
